Patients with NASH (versus simple steatosis alone) show significantly increased expression of IL-1β and TNFα, while increased IL-6 expression is seen in patients with portal fibrosis (versus lobular fibrosis) [287]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.